Detalhe da pesquisa
1.
Cancer Burden Is Controlled by Mural Cell-ß3-Integrin Regulated Crosstalk with Tumor Cells.
Cell
; 181(6): 1346-1363.e21, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473126
2.
Avacopan for the Treatment of ANCA-Associated Vasculitis.
N Engl J Med
; 384(7): 599-609, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596356
3.
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Proc Natl Acad Sci U S A
; 117(2): 1129-1138, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879345
4.
CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the Blood.
J Immunol
; 203(12): 3157-3165, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31676674
5.
Efficacy of Chemokine Receptor Inhibition in Treating IL-36α-Induced Psoriasiform Inflammation.
J Immunol
; 202(6): 1687-1692, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30718298
6.
Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells.
Proc Natl Acad Sci U S A
; 114(1): E85-E94, 2017 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986950
7.
IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin.
J Immunol
; 199(9): 3129-3136, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972090
8.
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models.
Int J Cancer
; 142(10): 2163-2174, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29277895
9.
CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.
Am J Physiol Gastrointest Liver Physiol
; 314(4): G483-G493, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420066
10.
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.
J Am Soc Nephrol
; 28(9): 2756-2767, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28400446
11.
Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue.
Circulation
; 129(11): 1244-53, 2014 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24374972
12.
CCR9 Antagonists in the Treatment of Ulcerative Colitis.
Mediators Inflamm
; 2015: 628340, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457007
13.
C5a receptor (CD88) blockade protects against MPO-ANCA GN.
J Am Soc Nephrol
; 25(2): 225-31, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24179165
14.
Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels.
Immunology
; 141(1): 111-22, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24116850
15.
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease.
Blood
; 120(7): 1449-57, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22618707
16.
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice.
Am J Physiol Renal Physiol
; 305(9): F1288-97, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23986513
17.
Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial.
Ann Rheum Dis
; 72(3): 337-44, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22589376
18.
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan.
Kidney Int Rep
; 8(4): 860-870, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069984
19.
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.
PLoS One
; 18(6): e0286724, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285333
20.
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
J Exp Med
; 203(9): 2201-13, 2006 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-16940167